Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:5.99.1.3 (
topoisomerase
)
9,911
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have isolated and sequenced 3 human
DNA topoisomerase II
(topo II) partial cDNA clones from a HeLa carcinoma cell cDNA library. Two clones were identical to an internal fragment of HeLa topo II cDNA. The third clone, CAA5, had a different and novel sequence which shared significant nucleotide (62%) and predicted peptide (70%) homologies with a region of the HeLa topo II cDNA. Our results suggest that HeLa cells express at least two homologous forms of
DNA topoisomerase II
. The new HeLa topo II homologue is discussed in relation to topo II isoenzymes recently described in a
Burkitt lymphoma
and other cell lines.
...
PMID:Isolation and characterization of a human cDNA clone encoding a novel DNA topoisomerase II homologue from HeLa cells. 216 84
A human
Burkitt lymphoma
cell line, Raji-HN2, made 10-fold more resistant to nitrogen mustard (HN2) than the parental Raji cell line, exhibited the following characteristics when compared to the parental Raji cells: (i) decreased HN2-induced DNA interstrand crosslinking; (ii) increased (3-fold)
DNA topoisomerase II
[DNA topoisomerase (ATP-hydrolyzing),
EC 5.99.1.3
] activity; (iii) increased (4- to 11-fold) sensitivity to
topoisomerase
II inhibitors; (iv) increased (2-fold) glutathione content; and (v) increased (2-fold) cell doubling time. The resistant phenotype was unstable and was maintained by weekly treatment of the cells with HN2. Growing the resistant cells in the absence of HN2 resulted in a time-dependent decrease in both resistance to HN2 and
topoisomerase
II activity and an increase in DNA interstrand crosslinking induced by HN2. We hypothesize that HN2 resistance is due to enhanced monoadduct repair with resultant decreased DNA crosslinking and that this process is mediated by
topoisomerase
II.
...
PMID:Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells. 282 70